HIPRA is an European multinational pharmaceutical company focused on prevention and diagnosis for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service.
HIPRA has a solid international presence with 39 subsidiaries in different countries, 2 production plants and 11 diagnostic centres. Moreover, our extensive international distribution network keeps open channels of marketing with nearly 100 other countries, thereby covering the five continents.
Research is a priority. HIPRA is the laboratory that has launched the most innovative vaccines and technology in the last ten years, with a total of 22 vaccines. The company allocates 10% of its annual revenue to R&D activities and 16% of its workforce is part of the R&D department.
HIPRA lies in 6th place in the worldwide ranking of animal health vaccines.
veterinary products, diagnostic service & diagnostic reagents, smart vaccination, medical devices for animal health, human health, one health, vaccines, covid19 vaccine
Outlook, Microsoft Office 365, Amazon AWS, SuccessFactors (SAP), Apache, Mobile Friendly, reCAPTCHA, YouTube, Google Font API, Google Tag Manager, IBM Websphere